Intent to Vaccinate Against SARS-CoV-2 and Its Determinants Across Six Ethnic Groups Living in Amsterdam, the Netherlands: a Cross-Sectional Analysis of the HELIUS Study (#6) | Sophie Campman, The Netherlands

International Workshop on COVID-19 Vaccines 2022 - June Edition

Uptake and Perceptions of COVID-19 Vaccine Among People Living With HIV in Zimbabwe: a Cross Sectional Study (#5) | Paul Kambamura, Zimbabwe

International Workshop on COVID-19 Vaccines 2022 - June Edition

Operationalisation of Model for Dynamics of COVID-19 in Kenya - Trajectory of Omicron Wave in Kenya (#4) | Shem Sam, Kenya

International Workshop on COVID-19 Vaccines 2022 - June Edition

Binding Antibody Responses to SARS-CoV-2 Variants from Alpha to Omicron after BNT162b2 Vaccination and Booster in Infection-Naïve and Previously-Infected (#3) | Jia Fu, United States

International Workshop on COVID-19 Vaccines 2022 - June Edition

No Pain, More Gain: Microneedle Vaccines for COVID-19 and Influenza (#1) | Sharon Vijayanand, United States

International Workshop on COVID-19 Vaccines 2022 - June Edition

COVID-19 Vaccination in Pregnant and Lactating Individuals | Ai-ris Yonekura Collier, MD

International Workshop on COVID-19 Vaccines 2022 - June Edition

Thrombosis and COVID-19 Vaccination | Steven Kerr, PhD

International Workshop on COVID-19 Vaccines 2022 - June Edition

Myocarditis and COVID-19 Vaccination | Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP

International Workshop on COVID-19 Vaccines 2022 - June Edition

Infection-Induced and Hybrid Immunity | Jefferson Jones, MD, MPH, LCDR USPHS

International Workshop on COVID-19 Vaccines 2022 - June Edition

Immune Correlates of Protection from SARS-CoV-2 Infection | Miles Philip Davenport, MB BS, D.Phil

International Workshop on COVID-19 Vaccines 2022 - June Edition

COVID-19 Vaccines - State of the Art | Kathryn Stephenson, MD, MPH

International Workshop on COVID-19 Vaccines 2022 - June Edition

SARS-CoV-2 Evolution: Where Do We Go From Here? | Jacob E. Lemieux, MD, DPhil

COVID-19 Clinical Forum 2022

International Workshop on HIV & Women 2023

Session 2 - Managing HIV Patients with Limited Treatment Options, Italian Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022

Session 1 - Managing HIV Patients with Limited Treatment Options, Italian Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022

Session 2 - Managing HIV Patients with Limited Treatment Options, Spanish Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022

Session 1 - Managing HIV Patients with Limited Treatment Options, Spanish Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022

Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis - Helen Xu

APACC 2022

Intensified Screening for Mycobacterial Infections Using Gen-xpert Directly in Blood and Mycobacterial Culture in Hospitalized Patients with Advanced HIV Diseases in Vietnam - Dieu Nguyen

APACC 2022

Effects of HIV-Integrated TB interventions on Care Continuum Outcomes for Active TB: A Systematic Review and Meta-Analysis - Gifty Marley

APACC 2022

High Sexually Transmitted Infection Prevalence / Incidence Among New, Current, and Non-Users of Pre-Exposure Prophylaxis and HIV-Positive Men Who Have Sex with Men and Transgender Women Attending Key Population-Led Clinics in Thai - Narukjaporn Thammajaru

APACC 2022

Impact of COVID-19 Lockdown on Testing for and Diagnoses of Sexually Transmitted Infections in Bangkok, Thailand - Napon Pungpapong

APACC 2022

Weight Change when Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV - Warittha Tieosapjaroen

APACC 2022

Asian Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes Through Week 96 - Shinichi Oka

APACC 2022